“purdue-pharma” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
San Diego Life Sciences Roundup: Otonomy, Verdezyne, and IPOs 05/02/14 San Diego
San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More 03/17/14 San Diego
Infinity Pharmaceuticals Snags $50M Extension From Mundipharma 11/29/11 Boston
Infinity Says Cash Stretches to 2014 01/07/11 Boston
Life Sciences Discovery Fund Debunks Perceptions with Omeros Deal, Shows State Can Bankroll Companies 12/14/10 Seattle
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets 10/25/10 Seattle
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise 02/09/10 Boston
$14M for Novomer, $7.3M for Innocentive, $6M for Zendesk, & More Boston-Area Deals News 08/21/09 Boston
Kolltan Adds $5M to Series A 08/18/09 Boston
Infinity Pharma Lead Cancer Drug Trial Halted, Ends in Failure 04/15/09 Boston
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca 12/11/08 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News 11/26/08 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News 11/24/08 Boston
Infinity Snags $75 Million Through Alliance with Purdue Pharma and Mundipharma 11/20/08 Boston
Page 1 of 1